Literature DB >> 28581007

Literature-based prediction of novel drug indications considering relationships between entities.

Giup Jang1, Taekeon Lee, Byung Mun Lee, Youngmi Yoon.   

Abstract

There have been many attempts to identify and develop new uses for existing drugs, which is known as drug repositioning. Among these efforts, text mining is an effective means of discovering novel knowledge from a large amount of literature data. We identify a gene regulation by a drug and a phenotype based on the biomedical literature. Drugs or phenotypes can activate or inhibit gene regulation. We calculate the therapeutic possibility that a drug acts on a phenotype by means of these two types of regulation. We assume that a drug treats a phenotype if the genes regulated by the phenotype are inversely correlated with the genes regulated by the drug. Based on this hypothesis, we identify drug-phenotype associations with therapeutic possibility. To validate the drug-phenotype associations predicted by our method, we make an enrichment comparison with known drug-phenotype associations. We also identify candidate drugs for drug repositioning from novel associations and thus reveal that our method is a novel approach to drug repositioning.

Mesh:

Year:  2017        PMID: 28581007     DOI: 10.1039/c7mb00020k

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  5 in total

1.  Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory.

Authors:  Hermann A M Mucke
Journal:  Front Pharmacol       Date:  2017-12-15       Impact factor: 5.810

Review 2.  Review of Drug Repositioning Approaches and Resources.

Authors:  Hanqing Xue; Jie Li; Haozhe Xie; Yadong Wang
Journal:  Int J Biol Sci       Date:  2018-07-13       Impact factor: 6.580

Review 3.  Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work.

Authors:  Rajesh Kumar; Seetha Harilal; Sheeba Varghese Gupta; Jobin Jose; Della Grace Thomas Parambi; Md Sahab Uddin; Muhammad Ajmal Shah; Bijo Mathew
Journal:  Eur J Med Chem       Date:  2019-08-08       Impact factor: 6.514

4.  Computationally repurposing drugs for breast cancer subtypes using a network-based approach.

Authors:  Forough Firoozbakht; Iman Rezaeian; Luis Rueda; Alioune Ngom
Journal:  BMC Bioinformatics       Date:  2022-04-20       Impact factor: 3.307

5.  Literature-Wide Association Studies (LWAS) for a Rare Disease: Drug Repurposing for Inflammatory Breast Cancer.

Authors:  Xiaojia Ji; Chunming Jin; Xialan Dong; Maria S Dixon; Kevin P Williams; Weifan Zheng
Journal:  Molecules       Date:  2020-08-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.